Clinical trial Recruiting at 18 sites Observational Ages 18 and up

Assessing remote monitoring functions in pacemakers

Official title: Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers

Run by MicroPort CRM · NCT05165095 · Data updated 2026-11-12

This study is testing how well remote monitoring features in certain pacemakers work to keep patients safe over four years after their surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment206 (estimated)
SponsorMicroPort CRM
Industry-sponsored
Locations19 sites (Krems and 18 other locations)
StatusRecruiting
StartedMarch 25, 2022
Main results expectedSeptember 5, 2023
Study endsJuly 2027
Registry record updatedMay 31, 2024
Trial IDNCT05165095 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients who have recently received an ALIZEA, BOREA, or CELEA dual chamber pacemaker and are eligible for remote monitoring.

Probably not a fit

Patients with elevated RV pacing thresholds, permanent atrial fibrillation, or those enrolled in conflicting clinical investigations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to evaluate the safety and performance of remote monitoring functions in the ALIZEA, BOREA, and CELEA pacemakers. Patients will be monitored for 48 months following implantation, with assessments conducted during scheduled follow-up visits. The study will measure the effectiveness of remote alerts and other monitoring features, ensuring patient safety throughout the duration of the investigation.

Why it matters

Potential benefit: If successful, this study could enhance the management of patients with bradycardia by improving the effectiveness of remote monitoring in pacemakers.

How similar studies have gone: Previous studies have shown promise in remote monitoring of cardiac devices, suggesting potential for success in this investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient implanted according to the most recent guidelines from the ESC, for 20 days or less (de novo implantation, device upgrade to dual chamber or device replacement)
2. Patient implanted with an ALIZEA, BOREA or CELEA dual chamber pacemaker from MicroPort CRM
3. Patient implanted with any active or passive CE marked bipolar RA lead, and any active or passive CE marked bipolar RV lead
4. Patient's pacemaker with the remote monitoring functions (i.e. the RAAT, the RVAT and the remote alerts) accepted by the patient and planned to be activated
5. Patient reviewed, signed and dated the ICF

Exclusion Criteria:

1. Patient with an elevated RV pacing threshold (strictly above 2.0 V for a pulse width of 0.5 ms or below)
2. Patient with permanent AF
3. Patient already enrolled in another clinical investigation that could confound the results of this clinical investigation (e.g., clinical investigations involving intra-cardiac device)
4. Patient implanted despite a contraindication for cardiac pacing system implantation (i.e. patient implanted with a defibrillator, patient contraindicated for a single dose of 310 μg of dexamethasone sodium phosphate, patient implanted with a tricuspid replacement heart valve or with a significant tricuspid valve disease that may lead to future replacement heart valve surgery)
5. Minor age patient (i.e. under 18 years of age)
6. Incapacitated patient, under guardianship, kept in detention, refusing to cooperate or not able to understand the purpose of this clinical investigation
7. Patient unavailable for the follow-up visits scheduled
8. Non-menopausal women

Where it's running

  • Universitätsklinikum Krems
    Krems, Austria
    Recruiting
  • Allgemeines Krankenhaus Wien
    Vienna, Austria
    Recruiting
  • Clinique Saint Joseph
    Arlon, Belgium
    Recruiting
  • CHU Bordeaux
    Bordeaux, France
    Recruiting
  • CH Chartres
    Le Coudray, France
    Recruiting
  • CHU Hôpital de la Timone
    Marseille, France
    Recruiting
Show 13 more locations
  • CHU Nantes
    Nantes, France
    Recruiting
  • Clinique Pasteur Toulouse
    Toulouse, France
    Recruiting
  • CH Valence
    Valence, France
    Recruiting
  • Cardiologicum Hamburg
    Hamburg, Germany
    Recruiting
  • Cardiologicum Pirna
    Pirna, Germany
    Recruiting
  • Kardiologische Praxis Dr. Trautwein & Dr. Placke
    Rostock, Germany
    Recruiting
  • Ziekenhuis VieCuri Venlo
    Venlo, Netherlands
    Recruiting
  • Hospital Professor Doutor Fernando Fonseca
    Amadora, Portugal
    Recruiting
  • Hospital Arquitecto Marcide
    Ferrol, Spain
    Recruiting
  • Hospital Universitario Puerta de Hierro
    Majadahonda, Spain
    Recruiting
  • Kingston Hospital
    London, United Kingdom
    Recruiting
  • Southend University Hospital
    Westcliff-on-Sea, United Kingdom
    Recruiting
  • Basildon University Hospital
    Basildon, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.